Paul Fronstin, director of Health Benefits Research at EBRI, discussed ERISA and trends in employer self-insurance during a conversation with Managed Healthcare Executive recently.
In its 50th anniversary this year, the Employee Retirement Income Security Act (ERISA), continues to allow employers to self-insure their health plans, highlights Paul Fronstin, director of Health Benefits Research at EBRI.
Fronstin discussed ERISA and trends in employer self-insurance during a conversation with Managed Healthcare Executive recently.
While large employers tend to choose self-insurance for consistency across states, smaller and mid-sized employers are now adopting it since the Affordable Care Act.
However, some revert to fully insured models after poor experiences.
Employees benefit from self-insurance through consistent benefits nationwide, Fronstin said.
“(Employees) don’t have to think about a new plan, a different network, or changing prescription drugs,” he said.
While most large employers include state-mandated benefits such as IVF, exceptions exist, he said.
Overall, large employers tend to offer generous health plans. Fronstin concluded that understanding these dynamics remains key to evaluating the self-insurance model’s effectiveness.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More